Open AccessAtorvastatin Given prior to Electrical Cardioversion Does Not Affect the Recurrence of Atrial Fibrillation in Patients with Persistent Atrial Fibrillation Who Are on Antiarrhythmic Therapy
Author(s) -
Kenan Demır,
İlknur Can,
Fatih Koç,
Mehmet Akıf Vatankulu,
Suzi Selim Ayhan,
Hakan Akıllı,
Alpay Arıbaş,
Yusuf İzzettin Alihanoğlu,
Bülent Behlül Altunkeser
Publication year - 2011
Publication title -
medical principles and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.426
H-Index - 45
eISSN - 1423-0151
pISSN - 1011-7571
DOI - 10.1159/000327674
Subject(s) - medicine , atorvastatin , atrial fibrillation , cardioversion , cardiology , clinical endpoint , gastroenterology , randomized controlled trial
In this study, our aim was to evaluate the effect of a higher dose of atorvastatin on the recurrence rate of atrial fibrillation (AF) after electrical cardioversion (EC) in addition to antiarrhythmic therapy.